Literature DB >> 24186056

Ultrasonic dissection system technology in breast cancer: a case-control study in a large cohort of patients requiring axillary dissection.

F Lumachi1, S M M Basso, D A Santeufemia, M Bonamini, G B Chiara.   

Abstract

In the sentinel node era, axillary dissection (ALND) for breast cancer (BC) is required much less frequently than in the past. However, complications, such as prolonged drainage output and seroma formation, are still observed. Harmonic dissection devices (HDDs) are widely used in laparoscopic and minimally invasive surgery to reduce collateral damage during tissue dissection, but its usefulness in breast surgery is unclear. The aim of this study was to evaluate the efficacy of HDDs compared to that of conventional dissection in performing ALND. One hundred thirty-nine women (median age 61 years, range 34-71 years) with confirmed pT1-2 primary infiltrating ductal BC undergoing curative surgery were enrolled in the study. The population was prospectively randomized between two age- and stage-matched arms: group A (cases)-68 (48.9 %) patients (HDD technique), versus group B (controls)-71 (51.1 %) patients (conventional technique). In group B, skin flaps were obtained using a scalpel, scissors, and electrocautery which was never used for ALND. In group A, for each operation time, the HDDs were used exclusively. The mean operative time, intraoperative blood loss, and drainage output were (A vs. B) 95 ± 22 versus 109 ± 25 min, 56 ± 12 versus 86 ± 15 mL, and 412 ± 83 versus 456 ± 69 mL, respectively (p < 0.01). Twenty-nine (20.9 %) patients developed an axillary seroma: 9 (13.2 %) and 20 (28.2 %) for groups A and B, respectively (p = 0.030). Our study confirms that in patients with BC requiring ALND the use of HDDs is more time efficient than conventional surgery, and reduces intraoperative bleeding, the amount of drainage, and the risk of seroma formation. These results may lead to several short- and long-term advantages. Thus, a careful evaluation of the cost-benefits of nontraditional tools, such as HDDs, should be performed in all patients undergoing modified radical or partial mastectomy and ALND for BC.

Entities:  

Mesh:

Year:  2013        PMID: 24186056     DOI: 10.1007/s10549-013-2746-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  The efficacy of oxidized regenerated cellulose (SurgiGuard®) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.

Authors:  Kug Hyun Nam; Joon-Hyop Lee; Yoo Seung Chung; Yong Soon Chun; Heung Kyu Park; Yun Yeong Kim
Journal:  PLoS One       Date:  2022-05-27       Impact factor: 3.752

2.  Prevention of lymphocele or seroma after mastectomy and axillary lymphadenectomy for breast cancer: systematic review and meta-analysis.

Authors:  Crestani Adrien; Mahiou Katia; Bodet Marie-Lucile; Roosen Alice; Bonneau Claire; Rouzier Roman
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

3.  A randomized controlled study comparing a vessel sealing system with the conventional technique in axillary lymph node dissection for primary breast cancer.

Authors:  Tomoko Seki; Tetsu Hayashida; Maiko Takahashi; Hiromitsu Jinno; Yuko Kitagawa
Journal:  Springerplus       Date:  2016-07-07

Review 4.  Performance of Harmonic devices in surgical oncology: an umbrella review of the evidence.

Authors:  Hang Cheng; Jeffrey W Clymer; Behnam Sadeghirad; Nicole C Ferko; Chris G Cameron; Joseph F Amaral
Journal:  World J Surg Oncol       Date:  2018-01-04       Impact factor: 2.754

5.  Impact of the Ultrasonic scalpel on the amount of drained lymph after axillary or inguinal lymphadenectomy.

Authors:  Olivier Gié; Marie-Laure Matthey-Gié; Pedro-Manuel Marques-Vidal; Nicolas Demartines; Maurice Matter
Journal:  BMC Surg       Date:  2017-03-21       Impact factor: 2.102

6.  Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.

Authors:  Hanchu Xiong; Zihan Chen; Ling Xu; Cong Chen; Qingshuang Fu; Rongyue Teng; Jida Chen; Shuduo Xie; Linbo Wang; Xiao-Fang Yu; Jichun Zhou
Journal:  Cancer Control       Date:  2020 Apr-Jun       Impact factor: 3.302

7.  Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.

Authors:  Claudio Gambardella; Guglielmo Clarizia; Renato Patrone; Chiara Offi; Claudio Mauriello; Roberto Romano; Marco Filardo; Alessandra Conzo; Alessandro Sanguinetti; Andrea Polistena; Nicola Avenia; Giovanni Conzo
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

Review 8.  Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer.

Authors:  Shoichiro Ishizuki; Yoshiyuki Nakamura
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.